Connect with us
We’re experimenting with AI-generated content to help deliver information faster and more efficiently.
While we try to keep things accurate, this content is part of an ongoing experiment and may not always be reliable.
Please double-check important details — we’re not responsible for how the information is used.

Disorders and Syndromes

“Placenta Plays Key Role in Genetic Risk for Schizophrenia and Other Neuropsychiatric Disorders”

An international team has identified associations between modifications in the placenta and the risk of developing schizophrenia, bipolar disorder, and major depression disorder.

Avatar photo

Published

on

The study, conducted by 28 researchers from 18 institutions across Europe and the United States, has shed light on the crucial role of the placenta in neuropsychiatric development. The research reveals that specific epigenetic modifications in the placenta, particularly DNA methylation, can significantly influence the expression of genes associated with psychiatric disorders such as schizophrenia, bipolar disorder, and major depression disorder.

DNA methylation is a chemical change that regulates gene activity without altering their sequence. This essential mechanism for development, environmental adaptation, and disease predisposition is influenced by genetics and responds to factors like diet, stress, and exposure to pollutants. The study results demonstrate a strong link between DNA methylation in the placenta and these neuropsychiatric disorders.

The findings reinforce the hypothesis that schizophrenia and other disorders have a neurodevelopmental origin, and the placenta plays a fundamental role in this process, as explained by Dr. Fernandez-Jimenez. This discovery opens new avenues for preventing and treating psychiatric disorders, allowing for intervention before symptoms appear and enabling personalized preventive strategies.

Moreover, the study highlights the importance of understanding where and when each genetic factor acts in pathology, which could impact therapeutic decision-making. Not all genes associated with a disorder should be treated directly; some may have acted in an earlier developmental stage and may not be actionable in adulthood, as concluded by Dr. Fernandez-Jimenez.

This research represents a significant advance in understanding the biological basis of neuropsychiatric disorders and opens new lines of investigation for early detection and more effective therapies. The study was conducted at IRLab (UPV/EHU and Biobizkaia), a multidisciplinary research group coordinated by Dr. José Ramón Bilbao, and involved collaboration with researchers from various institutions.

The implications of this research are substantial, offering new possibilities for preventing and treating psychiatric disorders. By identifying risk factors at the prenatal stage, healthcare professionals can intervene before symptoms appear, adjusting treatments or designing personalized preventive strategies. This knowledge can also inform therapeutic decision-making, taking into account where and when each genetic factor acts in pathology.

The study’s findings have far-reaching implications for our understanding of neuropsychiatric disorders and their development, emphasizing the importance of early detection and intervention. By shedding light on the role of the placenta in this process, researchers can develop more effective therapies and improve outcomes for individuals affected by these conditions.

Depression

The Dark Side of Brain Cells: How They May Contribute to Depression

Major depressive disorder affects hundreds of millions worldwide, but a key to understanding its origins may lie in the brain’s immune system. New findings spotlight astrocytes—previously overshadowed by microglia—as major players in neuroinflammation that drives depression. These star-shaped brain cells, once thought to only support neurons, are now shown to regulate communication between brain cells and even trigger or amplify inflammatory responses.

Avatar photo

Published

on

The brain cells meant to help us think and feel better may actually be making depression worse. Major depressive disorder (MDD) is a mental health condition that affects millions of people worldwide, causing a loss of interest in activities that were once enjoyable and leading to significant impairments in social and occupational functioning.

Research has shown that immune factors and cells, such as microglial cells, play a crucial role in driving neuroinflammation, which contributes to the development of MDD. However, a team of researchers led by Dr. Gaurav Singhal has shed light on the exact role of astrocytes, a specialized type of glial cell, in neural growth and development.

In their study, published in Neuroprotection, the research team conducted an in-depth review of literature to understand the role of astrocytes in neuroinflammation and MDD. They found that astrocytes are key to maintaining the structural integrity of synaptic junctions between neurons, promoting neurite growth and synapse formation.

However, changes in astrocyte morphology and function were associated with poor synaptic connectivity, contributing to the development of depressive symptoms. The researchers also discovered a critical mechanism involving activated microglia and astrocytes that resulted in sustained neuroinflammation in MDD.

The first step of this mechanism was the release of pro-inflammatory cytokines from activated microglia cells, which induced the secretion of additional inflammatory chemicals from astrocytes, amplifying neuroinflammation. Elaborating on the molecular crosstalk between microglia and astrocytes during MDD, Dr. Singhal explained that increased intracellular calcium levels within astrocytes can induce the release of adenosine triphosphate (ATP), which triggers a delayed calcium response in microglial cells.

Following multiple cycles of astrocyte-released ATP-based activation, microglial cells eventually undergo apoptosis or programmed cell death. Preclinical studies involving murine models showed that astrocytic lactate dehydrogenase A enzyme is important for maintaining neuronal excitability, and histone lactylation alters gene expression, contributing to astrocyte-driven neuroinflammation.

This study highlights the molecular mechanisms underlying astrocytic dysfunction, where astrocytes switch from a neuroprotective role to one that promotes neuroinflammation by increasing the expression and secretion of inflammatory cytokines. Understanding these mechanisms can aid in the development of therapeutic approaches to treat depression and other psychiatric disorders.

Continue Reading

Autism

CRISPR-edited stem cells hold key to understanding autism spectrum disorder

A team at Kobe University has created a game-changing resource for autism research: 63 mouse embryonic stem cell lines, each carrying a genetic mutation strongly associated with the disorder. By pairing classic stem cell manipulation with precise CRISPR gene editing, they ve built a standardized platform that mirrors autism-linked genetic conditions in mice. These models not only replicate autism-related traits but also expose key dysfunctions, like the brain s inability to clean up faulty proteins.

Avatar photo

Published

on

CRISPR technology has revolutionized genetics research, enabling scientists to edit genes with unprecedented precision. Recently, researchers at Kobe University developed a new method for modifying embryonic stem cells using CRISPR, creating a bank of 63 mouse embryonic stem cell lines containing the mutations most strongly associated with autism spectrum disorder (ASD). This breakthrough achievement has shed light on the hidden causes of ASD.

For decades, scientists have known that genetics play a significant role in the development of ASD. However, pinpointing the precise cause and mechanism remained elusive due to the lack of a standardized biological model for studying the effects of different mutations associated with the disorder. To address this challenge, Takumi Toru and his team at Kobe University embarked on a journey to create a reliable model by combining conventional manipulation techniques for mouse embryonic stem cells with CRISPR gene editing.

The new method proved highly efficient in making genetic variants of these cells, allowing the researchers to produce 63 mouse embryonic stem cell lines containing the mutations most strongly associated with ASD. These cell lines were further developed into various cell types and tissues, even generating adult mice with their genetic variations. The analysis of these cell lines revealed that autism-causing mutations often result in neurons being unable to eliminate misshapen proteins.

This finding is particularly interesting since the local production of proteins is a unique feature in neurons, and a lack of quality control of these proteins may be a causal factor of neuronal defects in ASD. Takumi expects that this achievement will be an invaluable resource for researchers studying autism and searching for drug targets. Moreover, the genetic variants studied are also implicated in other neuropsychiatric disorders such as schizophrenia and bipolar disorder, making this library potentially useful for studying these conditions as well.

This research was funded by various organizations, including the Japan Society for the Promotion of Science and the National Center of Neurology and Psychiatry. The study demonstrates the potential of CRISPR technology to reveal the hidden causes of complex diseases like ASD, paving the way for future discoveries and treatments.

Continue Reading

Diseases and Conditions

Finding the Perfect Balance: How Extra Weekend Hours Can Help Teens Manage Anxiety

Teens might finally have a good reason to sleep in on weekends within limits. A new study reveals that teenagers who get up to two extra hours of sleep on weekends show fewer anxiety symptoms than those who don t. But go beyond that sweet spot, and symptoms can actually increase.

Avatar photo

Published

on

A recent study has shed light on the benefits of getting extra sleep for teenagers, particularly on weekends. Researchers found that teens who got up to two more hours of sleep on weekends than on weekdays exhibited fewer symptoms of anxiety compared to those who didn’t catch up on their sleep.

The American Academy of Sleep Medicine recommends that teenagers aged 13 to 18 years old should aim for 8-10 hours of sleep each night. However, CDC data show that only 23% of high school students get sufficient sleep on average school nights. This can lead to problems such as depression and suicidal thoughts.

In contrast, the study found that moderate catch-up sleep – defined as less than two hours – was associated with lower anxiety symptoms. The researchers emphasized the importance of identifying the right amount of catch-up sleep for teens who restrict their sleep during the week.

Too little or too much sleep variability from weekday to weekend can contribute to symptoms like physical or mental fatigue and feelings of anxiety. Consistently getting sufficient sleep is crucial for overall health outcomes, including improved attention, behavior, learning, memory, emotional regulation, quality of life, and mental and physical health.

The study involved 1,877 adolescents with a mean age of 13.5 years. Sleep duration was estimated using Fitbit devices, while internalizing symptoms were assessed using the Child Behavior Checklist survey. The research abstract was published in an online supplement of the journal Sleep and will be presented at the SLEEP 2025 annual meeting.

The findings suggest that some weekend recovery sleep may be beneficial for teens, and it’s essential to find the perfect balance between weekday and weekend sleep to promote optimal health outcomes. By prioritizing sleep and establishing a consistent sleep schedule, teenagers can better manage anxiety and improve their overall well-being.

Continue Reading

Trending